Xeruborbactam clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2024
How each study uses xeruborbactam is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Xeruborbactam
- 1
Studies by the year they started
3 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2024 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Beta-lactamase inhibitors source
Studies
Open first, then newest update. How each study uses xeruborbactam is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal ImpairmentCompletedPhase 1Qpex Biopharma, Inc.NCT07104162Written as Cefiderocol/Xeruborbactam
- A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult ParticipantsCompletedPhase 1Qpex Biopharma, Inc.NCT06547554Written as Xeruborbactam
- Mass Balance Study of [14C]Xeruborbactam (QPX7728) in Healthy Adult Male ParticipantsCompletedPhase 1Qpex Biopharma, Inc.NCT07083817Written as [14C]Xeruborbactam
Codes
What other systems call xeruborbactam · ClinicalTrials.gg INT016324
- UNII (FDA) DE79L822UYXERUBORBACTAMOne source FDA
- NCI Thesaurus C184848XeruborbactamOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | DE79L822UY | XERUBORBACTAM | One source FDA |
| NCI Thesaurus | C184848 | Xeruborbactam | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.